Northern Trust Company of Connecticut’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Northern Trust Company of Connecticut’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$1.16M	Sell	30,158 -1,619	-5%	-$51.1K	0.01%	1318
2013 Q3	$871K	Sell	31,777 -968	-3%	-$22.9K	0.01%	1384
2013 Q2	$688K	Buy	+32,745	New	+$639K	﹤0.01%	1405

Other funds holding WX

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Company of Connecticut's WX Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) stake by 5.1% in Q4 2013, selling an estimated $51.1K and leaving 30,158 shares worth $1.16M. The position accounts for 0.01% of the portfolio, ranked #1318.

Northern Trust Company of Connecticut first reported a position in WX in Q2 2013 and has held it in 3 quarters since. 164 funds tracked by Wall St. Rank hold WX as of Q4 2013.

Northern Trust Company of Connecticut held 30,158 shares of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS worth $1.16M as of Q4 2013.
Northern Trust Company of Connecticut sold 1,619 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2013, an estimated $51.1K.
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS made up 0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1318 holding.
Northern Trust Company of Connecticut first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and has held it in 3 quarters since.
164 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.